At a glance
- Originator Nonindustrial source; University of Tennessee
- Developer Nonindustrial source
- Class Antiplatelets
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 24 Aug 1995 No-Development-Reported for Thrombosis in USA (Unknown route)